Transurethral seminal vesiculoscopy in the diagnosis and treatment of persistent or recurrent hemospermia: a single-institution experience

Liu, Zhiyong; Sun, Ying-hao; Xu, Chuanliang; Hou, Jian-Guo; Gao, Xu; Lü, Xin; Ye, Hua-Mao; Wang, Linhui; Gao, Xiaofeng

doi:10.1038/aja.2009.47

Cited by 37 publications

(54 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To date, few studies have focused on seminal vesiculoscopy in diagnosing and treating seminal vesiculitis. [11][12][13][14][15] The overall cure rate was reported as 78.6-97.6%, with the recurrence rate being <10%. [11][12][13][14][15] No severe complications were observed in these studies.…”

Section: Discussionmentioning

confidence: 99%

“…[11][12][13][14][15] The overall cure rate was reported as 78.6-97.6%, with the recurrence rate being <10%. [11][12][13][14][15] No severe complications were observed in these studies. [11][12][13][14][15] The present study investigated the use of transurethral seminal vesiculoscopy to analyse the cause of the seminal vesiculitis in 114 patients with an intractable form of the disease.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis

Liu

et al. 2014

J Int Med Res

View full text Add to dashboard Cite

Objective: To investigate the efficacy and safety of transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis. Methods: This prospective observational study enrolled patients with intractable seminal vesiculitis. The transurethral seminal vesiculoscope was inserted into the bilateral ejaculatory ducts and seminal vesicles, via the urethra. The ejaculatory ducts and seminal vesicles were visualized to confirm the diagnosis of seminal vesiculitis and to determine the cause of the disease. The seminal vesicles were washed repeatedly using 0.90% (w/v) sodium chloride before a 0.50% (w/v) levofloxacin solution was injected into the seminal vesicles. Results: A total of 114 patients participated in the study and 106 patients underwent bilateral seminal vesiculoscopy. Six patients with postoperative painful ejaculation were treated successfully with oral antibiotics and a-blockers. Two patients with postoperative epididymitis were treated successfully with a 1-week course of antibiotics. Haematospermia was alleviated in 94 of 106 patients (89%), and their pain and discomfort had either disappeared or had been obviously relieved, following treatment. Conclusion: Transurethral seminal vesiculoscopy is effective for diagnosing and treating intractable seminal vesiculitis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis

Liu

et al. 2014

J Int Med Res

View full text Add to dashboard Cite

show abstract

“…The findings included seminal vesicular inflammatory mucosal edema, congestion and hemorrhages affecting a single vesicle in 58.3% and both vesicles in 34.7% of patients. In addition, ejaculatory duct obstruction and calculi in one or both seminal vesicles and in the verumontanum lumen were found in a significant number of patients [Liu et al 2009].…”

Section: Conditions Of the Prostate And Seminal Vesicles Causing Hemamentioning

confidence: 99%

“…Transurethral seminal vesiculoscopy was successfully used to diagnose and treat patients with intractable hematospermia and seminal vesicle stones [Song et al 2012;Liu et al 2009] Prevalence of non-PE EjD in the general population Non-PE EjD is a common problem that has received little attention. Follow up of men, in a population-based cohort, revealed an annual incidence of EjD (difficulty to ejaculate or the amount of semen is a problem) of 24/1000 [Gades et al 2009].…”

Section: Termmentioning

confidence: 99%

A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men

Seyam

2013

Therapeutic Advances in Urology

View full text Add to dashboard Cite

BackgroundThere is an increasing interest in nonpremature ejaculatory dysfunction (non-PE EjD). The frontier of sexual medicine has shifted slowly from erectile dysfunction (ED) to premature ejaculation (PE) and now to non-PE EjD. Two factors have contributed to this shift. First is the search for new areas of research and of novel treatments and second is the better characterization of ejaculatory disorders. The development of questionnaires that better characterize the type of ejaculatory dysfunction (EjD) has helped to identify the problem with more precision in different populations.Interest in the global sexual practice patterns gave insight into the prevalence of non-PE EjD in different areas of the world. Within the non-PE EjD itself, a shift in focus occurred over the years. Early and related to prostatic surgery and retroperitoneal lymph node dissection (RPLND) retrograde ejaculation was reported. With the development of α-blockers and finasteride, retrograde ejaculation, EjD and/or orgasmic dysfunction were reported as A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men Raouf SeyamAbstract Introduction: A better understanding of ejaculatory disorders has led to an increasing interest in nonpremature ejaculatory dysfunction (non-PE EjD). Current reviews on the subject use a symptom-based classification to describe ejaculatory dysfunction even when it is a single case report. While these reviews provide important information on the disorder, a clearer picture of the prevalence of non-PE EjD in relation to the community and various pathophysiologic states is needed. Objectives: The objective of this study was to provide a systematic review of studies of non-PE EjD excluding single case reports. Methods: A systematic review of Medline for terms including ejaculation, orgasm or hematospermia. Association with terms delay, pain or headache was made. The search was restricted to male gender and articles written in English. Abstracts were reviewed and those mainly concerned with premature ejaculation were excluded. Results: A total of 333 articles on non-PE EjD were identified. The condition was reported in community-based studies. In certain patient populations, non-PE EjD was commonly reported in association with antidepressant and antipsychotic treatments, in patients with chronic prostatitis/chronic pelvic pain syndrome, patients with lower urinary tract symptoms particularly in association with medical or surgical treatment, patients with retroperitoneal surgery and in patients with neurological diseases. Few articles were concerned with treatment options. Conclusion: There is a significant prevalence of non-PE EjD in the community and in association with particular disease states or as a side effect of medical or surgical interventions. There is a need to direct efforts to prevent and treat these conditions. Keywords: anhedonia, aspermia, ejaculation, epidemiology, headache, hemospermia, orgasm, pain, prevalence adverse events. It became clear ...

show abstract

“…Cystoscopic observation of the openings of ejaculatory or prostatic ducts with simultaneous prostate massage may be useful to localize bleeding [3]. Recently, Liu et al [48] demonstrated that transurethral seminal vesiculoscopy is useful in the diagnosis and treatment as well (Fig. 1).…”

Section: Imaging Techniquementioning

confidence: 99%

Hematospermia: etiology, diagnosis, and treatment

Fuse

Komiya

Nozaki

et al. 2011

Reprod Medicine & Biology

View full text Add to dashboard Cite

Hematospermia is a relatively frequent, distressing, and frightening symptom for the majority of men. Although the differential diagnosis list is extensive, it is usually a benign, self-limiting disorder, including inflammatory and infective pathologies, resolving in several weeks. However, in some cases, hematospermia is the harbinger of more serious pathological lesions that should not be missed. In younger patients below 40 years of age, infection of the urogenital tract is the most common etiology. Simple routine laboratory studies should identify the pathological factors. In patients 40 years or older, or those with persistent or recurrent conditions or associated symptoms, it is necessary to exclude urogenital malignant disorders. Patients should also undergo medical history taking, physical examination including temperature and blood pressure assessment, digital rectal palpation, and laboratory blood, urine, and semen tests. If the diagnosis is still unclear, further investigations involve transrectal ultrasonography, magnetic resonance imaging, urethrocystoscopy, and histological confirmation by biopsy. Treatment for hematospermia depends on the underlying pathological lesions, but often involves only minimal examinations and simple reassurance in most cases. Hematospermia caused by genitourinary infections is effectively treated with appropriate antiviral, antibiotic, or antiparasitic agents. Hematospermia due to malignant disorders including prostate, testis, and seminal vesicle cancers resolves with definitive treatment of the primary lesions.

show abstract

Transurethral seminal vesiculoscopy in the diagnosis and treatment of persistent or recurrent hemospermia: a single-institution experience

Cited by 37 publications

References 7 publications

Transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis

Transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis

A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men

Hematospermia: etiology, diagnosis, and treatment

Contact Info

Product

Resources

About